According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.

An affiliate of Bain Capital will acquire 51 per cent of the injection molding and extrusion machinery maker from current owner Hillenbrand Inc.

Dubai Bain Capital is in the final stages of negotiations to acquire Mitsubishi Chemical Group's pharmaceutical subsidiary, ...

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the "Company"), a globally renowned provider of ...

Ategrity Specialty Insurance Co., a provider of excess and surplus insurance to small and midsize US companies, is exploring ...

Canadian pension fund CPP Investments is weighing strategic options, including a sale or initial public offering, for Encino Acquisition Partners that could value the U.S. oil and natural gas producer ...

KBRA assigns a rating of BBB to Bain Capital Specialty Finance, Inc.'s ("BCSF" or "the company") $350 million, 5.95% senior unsecured notes due 2030. The rating Outlook is Stable. The proceeds will be ...

Bain Capital Specialty Finance (NYSE:BCSF – Get Free Report) had its price target lifted by analysts at Wells Fargo & Company from $17.00 to $18.00 in a research note issued to investors on Wednesday, ...

BOSTON - Bain Capital Specialty Finance , Inc. (NYSE:BCSF), a business development company with a market capitalization of $1 ...